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Background:  
                   Subclinical hypothyroidism is a concept recently developed with the advent of 
sensitive TSH assays. Being an independent predictor of cardiovascular morbidity and 
mortality, it is 4 -10% prevalent in the general population. A higher prevalence of clinical 
and subclinical primary hypothyroidism exists in CKD patients leading to ESRD earlier. 
This study was intended to evaluate the prevalence of thyroid abnormalities mainly 
Subclinical Hypothyroidism  in various stages of CKD patients, who are not undergoing 
dialysis. 
Aims and objectives: 
               To study the prevalence of Subclinical Hypothyroidism and its correlation with  
various stages of chronic kidney disease. 
Materials and methods: 
              50 CKD patients in the predialysis phase and 50 healthy controls, who attend the 
regular OPD in SMC&H are selected for our study. Serum urea, creatinine, total protein, 
TSH  and free T4 levels are estimated. Staging of CKD done with the eGFR calculated using 
MDRD formula and the prevalence of subclinical hypothyroidism with TSH levels 
<10mIU/mL are studied in these patients and compared with the control population. 
 
Results: 
                         Subclinical hypothyroidism is more prevalent in CKD patients (40%) when 
compared with the general population (6%). Subclinical hypothyroidism was found to be 
8%, 10%, 20% and 12% in the stages II, III, IV and V of CKD patients and it gradually 
increases as the stage of the CKD advances. As the eGFR falls, TSH starts increasing due to 
alteration in the hypothalamo-pituitary axis, TSH glycosylation and diurnal rhythm. It may 
also be due to altered metabolism of thyroid hormones and decreased peripheral conversion 
of T4 to T3.The exact mechanisms linking CKD and hypothyroidism are still unclear. 
Conclusion: 
                     From the results of our study, we conclude that the prevalence of Subclinical 
hypothyroidism is high among all the stages of CKD patients. Also the incidence of thyroid 
abnormalities increases, as the stage of CKD advances with fall in GFR. Need for treatment 
depends on the patient’s clinical scenario and decision of the clinician based on the 
presentation. Many more clinical trials are needed to prove the need for thyroxine 
replacement. 
Future perspective: 
                    Follow-up of patients to know whether patients with thyroid abnormalities 
progress to ESRD earlier in comparison with patients without thyroid abnormality and also 
the incidence of cardiovascular morbidity and mortality in these patients. 
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